Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis
Abstract Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on...
Saved in:
Published in | Rheumatology (Oxford, England) Vol. 64; no. 8; pp. 4525 - 4538 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.08.2025
Oxford Publishing Limited (England) Oxford University Press (OUP) |
Subjects | |
Online Access | Get full text |
ISSN | 1462-0324 1462-0332 1462-0332 |
DOI | 10.1093/rheumatology/keaf164 |
Cover
Abstract | Abstract
Objectives
We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies.
Methods
Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs.
Results
The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case–control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18–1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00).
Conclusion
Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment). |
---|---|
AbstractList | We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies.
Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs.
The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case-control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61-0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18-1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41-1.00).
Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment). We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and meta-analysis of observational studies.OBJECTIVESWe aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and meta-analysis of observational studies.Three databases (MEDLINE, EMBASE, WEB OF SCIENCE) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (OR) and their 95% confidence interval (CI).METHODSThree databases (MEDLINE, EMBASE, WEB OF SCIENCE) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (OR) and their 95% confidence interval (CI).The search strategy identified 4,210 references, of which 43 studies were analyzed and 17 were included in the meta-analysis (11 case-control studies, four cohort studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61-0.93) and whereas history of cardiovascular disease was positively associated with GCA with risk (OR = 1.28, 95% CI 1.18-1.38). We found a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41-1.00).RESULTSThe search strategy identified 4,210 references, of which 43 studies were analyzed and 17 were included in the meta-analysis (11 case-control studies, four cohort studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61-0.93) and whereas history of cardiovascular disease was positively associated with GCA with risk (OR = 1.28, 95% CI 1.18-1.38). We found a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41-1.00).Our study showed an inverse association of type 2 diabetes and a positive association of a history of cardiovascular disease with GCA risk. There is also a trend towards an inverse association with overweight. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors such as diet, or a condition following their diagnosis such as their treatment.CONCLUSIONOur study showed an inverse association of type 2 diabetes and a positive association of a history of cardiovascular disease with GCA risk. There is also a trend towards an inverse association with overweight. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors such as diet, or a condition following their diagnosis such as their treatment. Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs. Results The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case–control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18–1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment). Abstract Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies. Methods Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs. Results The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case–control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR = 1.28, 95% CI 1.18–1.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment). Abstract Objectives We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and meta-analysis of observational studies. Methods Three databases (MEDLINE, EMBASE, WEB OF SCIENCE) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (OR) and their 95% confidence interval (CI). Results The search strategy identified 4,210 references, of which 43 studies were analyzed and 17 were included in the meta-analysis (11 case-control studies, four cohort studies). An inverse association was found between type 2 diabetes and risk of GCA (OR = 0.75, 95% CI 0.61–0.93) and whereas history of cardiovascular disease was positively associated with GCA with risk (OR = 1.28, 95% CI 1.18–1.38). We found a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41–1.00). Conclusion Our study showed an inverse association of type 2 diabetes and a positive association of a history of cardiovascular disease with GCA risk. There is also a trend towards an inverse association with overweight. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors such as diet, or a condition following their diagnosis such as their treatment. |
Author | Pacoureau, Lucas Nguyen, Yann Seror, Raphaèle Barde, François Elbaz, Alexis |
Author_xml | – sequence: 1 givenname: François orcidid: 0000-0002-5652-225X surname: Barde fullname: Barde, François – sequence: 2 givenname: Lucas surname: Pacoureau fullname: Pacoureau, Lucas – sequence: 3 givenname: Alexis orcidid: 0000-0001-9724-5490 surname: Elbaz fullname: Elbaz, Alexis – sequence: 4 givenname: Raphaèle surname: Seror fullname: Seror, Raphaèle email: Raphaele.seror@aphp.fr – sequence: 5 givenname: Yann orcidid: 0000-0002-0866-3824 surname: Nguyen fullname: Nguyen, Yann |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40127188$$D View this record in MEDLINE/PubMed https://hal.science/hal-05039673$$DView record in HAL |
BookMark | eNqN0U1r2zAYB3AxOtaX7RuMIdilO7iRLNmRdwulXQeBXbazeSw_atTaUibJKTn2m1dpsjB22kkP4vfXC_9zcuK8Q0I-cnbFWSNmYYXTCMkP_n47e0QwvJZvyBmXdVkwIcqT41zKU3Ie4wNjrOJCvSOnkvFyzpU6I8-LGL22kKx3tMP0hOiohtBbv4GopwECDTY-UgM6-RApuJ6mFVKv9RQCOp1HQ-8tuEQ1DgOFkDDYZONXCjRuY8L8SqtpwI3Fp9f8iAkKcDBso43vyVsDQ8QPh_WC_Lq9-Xl9Vyx_fPt-vVgWWtQsFVh2iGxupGqkkR2UzKBhQklpVI1V13GtBe-6su-AM6aqHrSpUfG-nNc11-KCfNmfu4KhXQc7Qti2Hmx7t1i2uz1WMdHUc7Hh2V7u7Tr43xPG1I427n4HDv0UW8EVa1T2KtPP_9AHP4X8t6xKUYlGCsmy-nRQUzdif7z_TxEZyD3QwccY0BwJZ-2u7_bvvttD3zk228f8tP6_xAt6IbUn |
Cites_doi | 10.1136/rmdopen-2020-001285 10.1093/rap/rkaa018 10.1093/rheumatology/keaa111.184 10.1007/s12026-013-8409-8 10.1056/NEJM198107093050216 10.1016/j.jacc.2003.12.047 10.3899/jrheum.121150 10.1093/rheumatology/keaa080 10.1097/WNO.0000000000000218 10.3390/jcm11102905 10.1136/rmdopen-2023-003493 10.3109/14397595.2015.1081722 10.1016/j.semarthrit.2020.05.003 10.7326/M12-3046 10.1016/j.semarthrit.2023.152298 10.1093/ije/18.4.836 10.1002/art.1780380311 10.1111/1756-185X.12631 10.3899/jrheum.220610 10.1136/annrheumdis-2013-204113 10.1016/j.jbspin.2018.05.011 10.1111/j.1756-185X.2010.01527.x 10.1093/rheumatology/keu331 10.1177/1937586717747384 10.3899/jrheum.140906 10.1093/rap/rky024 10.1136/ard.2009.111005 10.1002/art.1780330810 10.1016/j.ejim.2018.10.004 10.1016/j.semarthrit.2018.07.001 10.1093/rap/rkad095 10.1016/j.jaut.2009.12.003 10.1016/j.pharmthera.2020.107614 10.3109/03009742.2014.982701 10.7326/0003-4819-123-3-199508010-00006 10.1136/rmdopen-2022-002640 10.1016/j.phrs.2014.03.001 10.1002/art.24459 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X 10.3390/ijms24010755 10.1080/03009742.2018.1506821 10.1016/j.semarthrit.2021.09.006 10.1002/acr.22416 10.1016/j.envint.2024.108602 |
ContentType | Journal Article |
Copyright | The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2025 The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2025 – notice: The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP K9. NAPCQ 7X8 1XC |
DOI | 10.1093/rheumatology/keaf164 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1462-0332 |
EndPage | 4538 |
ExternalDocumentID | oai_HAL_hal_05039673v1 40127188 10_1093_rheumatology_keaf164 10.1093/rheumatology/keaf164 |
Genre | Meta-Analysis Systematic Review Journal Article |
GrantInformation_xml | – fundername: Fondation pour la Recherche Médicale grantid: FDM202306017277 |
GroupedDBID | --- -E4 .2P .GJ .I3 .XZ .ZR 08P 0R~ 18M 1TH 29P 2WC 354 3O- 4.4 48X 53G 5RE 5VS 5WA 5WD 70D AABZA AACZT AAGKA AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNGD ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABVGC ABXVV ABZBJ ACFRR ACGFO ACGFS ACPRK ACUFI ACUKT ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEHUL AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGORE AGQPQ AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQDSO ATGXG ATTQO AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MHKGH N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBH OCZFY ODMLO OHH OJQWA OJZSN OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y R44 RD5 RNI ROL ROX RUSNO RW1 RXO RZF RZO SV3 TCURE TEORI TJX TMA TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZGI ZKX ZY1 ~91 AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP K9. NAPCQ 7X8 1XC |
ID | FETCH-LOGICAL-c360t-e2bee07f4894f4ba20fef03844f86e5bb1cc31bb2dba10085dacf6e81d27661c3 |
ISSN | 1462-0324 1462-0332 |
IngestDate | Fri Sep 12 12:40:37 EDT 2025 Thu Jul 10 19:30:53 EDT 2025 Mon Aug 04 10:10:37 EDT 2025 Wed Aug 06 16:36:22 EDT 2025 Thu Aug 07 06:02:03 EDT 2025 Mon Sep 15 00:05:45 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | giant cell arteritis cardiovascular disease smoking meta-analysis diabetes mellitus cardiovascular risk factors dyslipidemia systematic review hypertension polymyalgia rheumatica |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights) https://academic.oup.com/pages/standard-publication-reuse-rights The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c360t-e2bee07f4894f4ba20fef03844f86e5bb1cc31bb2dba10085dacf6e81d27661c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5652-225X 0000-0001-9724-5490 0000-0002-0866-3824 0000-0002-5523-1856 |
PMID | 40127188 |
PQID | 3235394340 |
PQPubID | 41027 |
PageCount | 14 |
ParticipantIDs | hal_primary_oai_HAL_hal_05039673v1 proquest_miscellaneous_3180985038 proquest_journals_3235394340 pubmed_primary_40127188 crossref_primary_10_1093_rheumatology_keaf164 oup_primary_10_1093_rheumatology_keaf164 |
PublicationCentury | 2000 |
PublicationDate | 2025-08-01 |
PublicationDateYYYYMMDD | 2025-08-01 |
PublicationDate_xml | – month: 08 year: 2025 text: 2025-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Rheumatology (Oxford, England) |
PublicationTitleAlternate | Rheumatology (Oxford) |
PublicationYear | 2025 |
Publisher | Oxford University Press Oxford Publishing Limited (England) Oxford University Press (OUP) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) – name: Oxford University Press (OUP) |
References | Chandran (2025080115361602300_keaf164-B48) 2015; 44 Ungprasert (2025080115361602300_keaf164-B11) 2016; 19 Jakobsson (2025080115361602300_keaf164-B24) 2015; 54 Brennan (2025080115361602300_keaf164-B12) 2018; 48 Pugnet (2025080115361602300_keaf164-B27) 2015; 42 Kakafika (2025080115361602300_keaf164-B41) 2007; 71 Li (2025080115361602300_keaf164-B9) 2017; 56 Kang (2025080115361602300_keaf164-B17) 2022; 74 Salvarani (2025080115361602300_keaf164-B47) 1995; 123 Udayakumar (2025080115361602300_keaf164-B34) 2015; 67 Kermani (2025080115361602300_keaf164-B2) 2010; 69 Tomasson (2025080115361602300_keaf164-B3) 2014; 160 Nojima (2025080115361602300_keaf164-B54) 2023; 24 World Health Organization. Obesity (2025080115361602300_keaf164-B37) Esen (2025080115361602300_keaf164-B23) 2023; 9 Ulivieri (2025080115361602300_keaf164-B52) 2014; 88 Greigert (2025080115361602300_keaf164-B5) 2022; 11 Arnson (2025080115361602300_keaf164-B39) 2010; 34 Garvey (2025080115361602300_keaf164-B45) 2021; 51 Dehnavi (2025080115361602300_keaf164-B53) 2020; 214 Singh (2025080115361602300_keaf164-B19) 2018; 2 Singh (2025080115361602300_keaf164-B30) 2019; 86 Moretti (2025080115361602300_keaf164-B42) 2024; 42 Chatzigeorgiou (2025080115361602300_keaf164-B21) 2023; 7 Hunder (2025080115361602300_keaf164-B13) 1990; 33 Elfishawi (2025080115361602300_keaf164-B8) 2023; 50 Turkiewicz (2025080115361602300_keaf164-B33) 2020; 6 Barde (2025080115361602300_keaf164-B50) 2024; 64 Ungprasert (2025080115361602300_keaf164-B10) 2016; 26 Caudrelier (2025080115361602300_keaf164-B49) 2019; 60 Gonzalez-Gay (2025080115361602300_keaf164-B1) 2009; 61 Pujades-Rodriguez (2025080115361602300_keaf164-B4) 2016; 102 Schmidt (2025080115361602300_keaf164-B29) 2013; 40 Higgins (2025080115361602300_keaf164-B14) 2024; 186 Spray (2025080115361602300_keaf164-B31) 2020; 59 Robson (2025080115361602300_keaf164-B28) 2015; 74 Feingold (2025080115361602300_keaf164-B44) 2000 Machado (2025080115361602300_keaf164-B25) 1989; 18 Duhaut (2025080115361602300_keaf164-B22) 1998; 41 Pati (2025080115361602300_keaf164-B15) 2018; 11 Mukhtyar (2025080115361602300_keaf164-B26) 2020; 4 Yates (2025080115361602300_keaf164-B36) 2017; 56 Barrier (2025080115361602300_keaf164-B6) 1981; 305 Ungprasert (2025080115361602300_keaf164-B43) 2015; 3 World Health Organization. Cardiovascular diseases (CVDs) (2025080115361602300_keaf164-B38) Hoganson (2025080115361602300_keaf164-B16) 2010; 13 Partington (2025080115361602300_keaf164-B18) 2020; 50 Khattri (2025080115361602300_keaf164-B51) 2013; 56 Ambrose (2025080115361602300_keaf164-B40) 2004; 43 Abel (2025080115361602300_keaf164-B20) 2015; 35 Pacoureau (2025080115361602300_keaf164-B7) 2023; 9 Salvarani (2025080115361602300_keaf164-B46) 1995; 38 Wadström (2025080115361602300_keaf164-B35) 2020; 59 Tomasson (2025080115361602300_keaf164-B32) 2019; 48 |
References_xml | – volume: 6 start-page: e001285 year: 2020 ident: 2025080115361602300_keaf164-B33 article-title: Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study publication-title: RMD Open. doi: 10.1136/rmdopen-2020-001285 – volume: 4 start-page: rkaa018 year: 2020 ident: 2025080115361602300_keaf164-B26 article-title: The relationship between glycated haemoglobin levels and the risk of giant cell arteritis—a case-control study publication-title: Rheumatol Adv Pract doi: 10.1093/rap/rkaa018 – ident: 2025080115361602300_keaf164-B37 – volume: 56 start-page: 753 year: 2017 ident: 2025080115361602300_keaf164-B9 article-title: Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink publication-title: Rheumatology – volume: 59 year: 2020 ident: 2025080115361602300_keaf164-B31 article-title: P189 Diabetes may confer protection from giant cell arteritis: results from a large inception cohort publication-title: Rheumatology doi: 10.1093/rheumatology/keaa111.184 – volume: 56 start-page: 348 year: 2013 ident: 2025080115361602300_keaf164-B51 article-title: Statins and autoimmunity publication-title: Immunol Res doi: 10.1007/s12026-013-8409-8 – volume: 305 start-page: 104 year: 1981 ident: 2025080115361602300_keaf164-B6 article-title: Increased prevalence of HLA-DR4 in giant-cell arteritis publication-title: N Engl J Med doi: 10.1056/NEJM198107093050216 – volume: 43 start-page: 1731 year: 2004 ident: 2025080115361602300_keaf164-B40 article-title: The pathophysiology of cigarette smoking and cardiovascular disease: an update publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.12.047 – volume: 40 start-page: 910 year: 2013 ident: 2025080115361602300_keaf164-B29 article-title: Statin use in giant cell arteritis: a retrospective study publication-title: J Rheumatol doi: 10.3899/jrheum.121150 – ident: 2025080115361602300_keaf164-B38 – volume: 59 start-page: 3229 year: 2020 ident: 2025080115361602300_keaf164-B35 article-title: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis publication-title: Rheumatol Oxf Engl doi: 10.1093/rheumatology/keaa080 – volume: 35 start-page: 134 year: 2015 ident: 2025080115361602300_keaf164-B20 article-title: Effect of diabetes mellitus on giant cell arteritis publication-title: J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc doi: 10.1097/WNO.0000000000000218 – volume: 11 start-page: 2905 year: 2022 ident: 2025080115361602300_keaf164-B5 article-title: New insights into the pathogenesis of giant cell arteritis: mechanisms involved in maintaining vascular inflammation publication-title: J Clin Med doi: 10.3390/jcm11102905 – volume: 9 start-page: e003493 year: 2023 ident: 2025080115361602300_keaf164-B7 article-title: Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis publication-title: RMD Open. doi: 10.1136/rmdopen-2023-003493 – volume: 26 start-page: 410 year: 2016 ident: 2025080115361602300_keaf164-B10 article-title: Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: a systematic review and meta-analysis publication-title: Mod Rheumatol doi: 10.3109/14397595.2015.1081722 – volume: 50 start-page: 663 year: 2020 ident: 2025080115361602300_keaf164-B18 article-title: Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: a case control and cohort study publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2020.05.003 – volume: 42 start-page: 1321 year: 2024 ident: 2025080115361602300_keaf164-B42 article-title: The role of tobacco smoking in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review publication-title: Clin Exp Rheumatol – volume: 160 start-page: 73 year: 2014 ident: 2025080115361602300_keaf164-B3 article-title: Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study publication-title: Ann Intern Med doi: 10.7326/M12-3046 – volume: 64 start-page: 152298 year: 2024 ident: 2025080115361602300_keaf164-B50 article-title: Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: a validation study publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2023.152298 – volume: 71 start-page: 1173 year: 2007 ident: 2025080115361602300_keaf164-B41 article-title: Smoking and aortic diseases publication-title: Circ J Off J Jpn Circ Soc – volume: 18 start-page: 836 year: 1989 ident: 2025080115361602300_keaf164-B25 article-title: A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? publication-title: Int J Epidemiol doi: 10.1093/ije/18.4.836 – volume: 38 start-page: 369 year: 1995 ident: 2025080115361602300_keaf164-B46 article-title: Epidemiology of polymyalgia rheumatica in Olmsted county, Minnesota, 1970–1991 publication-title: Arthritis Rheum doi: 10.1002/art.1780380311 – volume: 19 start-page: 819 year: 2016 ident: 2025080115361602300_keaf164-B11 article-title: Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.12631 – volume: 3 start-page: 232 year: 2015 ident: 2025080115361602300_keaf164-B43 article-title: Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis publication-title: Ann Transl Med – volume: 50 start-page: 526 year: 2023 ident: 2025080115361602300_keaf164-B8 article-title: Lower frequency of comorbidities prior to onset of giant cell arteritis: a population-based study publication-title: J Rheumatol doi: 10.3899/jrheum.220610 – volume: 74 start-page: 129 year: 2015 ident: 2025080115361602300_keaf164-B28 article-title: The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204113 – volume: 86 start-page: 219 year: 2019 ident: 2025080115361602300_keaf164-B30 article-title: The association of gout with incident giant cell arteritis in older adults publication-title: Joint Bone Spine doi: 10.1016/j.jbspin.2018.05.011 – volume: 13 start-page: e1 year: 2010 ident: 2025080115361602300_keaf164-B16 article-title: Lack of association of high body mass index with risk for developing polymyalgia rheumatica publication-title: Int J Rheum Dis doi: 10.1111/j.1756-185X.2010.01527.x – volume: 54 start-page: 433 year: 2015 ident: 2025080115361602300_keaf164-B24 article-title: Body mass index and the risk of giant cell arteritis: results from a prospective study publication-title: Rheumatology doi: 10.1093/rheumatology/keu331 – volume: 74 issue: Suppl 9 year: 2022 ident: 2025080115361602300_keaf164-B17 – volume: 11 start-page: 15 year: 2018 ident: 2025080115361602300_keaf164-B15 article-title: How to write a systematic review of the literature publication-title: HERD doi: 10.1177/1937586717747384 – volume: 42 start-page: 316 year: 2015 ident: 2025080115361602300_keaf164-B27 article-title: Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study publication-title: J Rheumatol doi: 10.3899/jrheum.140906 – volume: 2 start-page: rky024 year: 2018 ident: 2025080115361602300_keaf164-B19 article-title: The risk of polymyalgia rheumatica in older adults with gout: a Medicare claims study publication-title: Rheumatol Adv Pract doi: 10.1093/rap/rky024 – volume: 69 start-page: 780 year: 2010 ident: 2025080115361602300_keaf164-B2 article-title: Increase in age at onset of giant cell arteritis: a population-based study publication-title: Ann Rheum Dis doi: 10.1136/ard.2009.111005 – volume: 33 start-page: 1122 year: 1990 ident: 2025080115361602300_keaf164-B13 article-title: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis publication-title: Arthritis Rheum doi: 10.1002/art.1780330810 – volume: 60 start-page: e16 year: 2019 ident: 2025080115361602300_keaf164-B49 article-title: Validation of giant cell arteritis diagnosis code in the French hospital electronic database publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2018.10.004 – volume: 48 start-page: 529 year: 2018 ident: 2025080115361602300_keaf164-B12 article-title: Smoking as a risk factor for giant cell arteritis: a systematic review and meta-analysis publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2018.07.001 – volume: 7 start-page: rkad095 year: 2023 ident: 2025080115361602300_keaf164-B21 article-title: Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank publication-title: Rheumatol Adv Pract doi: 10.1093/rap/rkad095 – volume: 34 start-page: J258 year: 2010 ident: 2025080115361602300_keaf164-B39 article-title: Effects of tobacco smoke on immunity, inflammation and autoimmunity publication-title: J Autoimmun. doi: 10.1016/j.jaut.2009.12.003 – volume: 214 start-page: 107614 year: 2020 ident: 2025080115361602300_keaf164-B53 article-title: Statins and autoimmunity: state-of-the-art publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2020.107614 – volume-title: Endotext year: 2000 ident: 2025080115361602300_keaf164-B44 – volume: 44 start-page: 215 year: 2015 ident: 2025080115361602300_keaf164-B48 article-title: The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009 publication-title: Scand J Rheumatol doi: 10.3109/03009742.2014.982701 – volume: 123 start-page: 192 year: 1995 ident: 2025080115361602300_keaf164-B47 article-title: The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern publication-title: Ann Intern Med doi: 10.7326/0003-4819-123-3-199508010-00006 – volume: 9 start-page: e002640 year: 2023 ident: 2025080115361602300_keaf164-B23 article-title: Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort publication-title: RMD Open doi: 10.1136/rmdopen-2022-002640 – volume: 56 start-page: 524 year: 2017 ident: 2025080115361602300_keaf164-B36 article-title: The association of vascular risk factors with visual loss in giant cell arteritis publication-title: Rheumatology – volume: 88 start-page: 41 year: 2014 ident: 2025080115361602300_keaf164-B52 article-title: Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases publication-title: Pharmacol Res doi: 10.1016/j.phrs.2014.03.001 – volume: 61 start-page: 1454 year: 2009 ident: 2025080115361602300_keaf164-B1 article-title: Epidemiology of giant cell arteritis and polymyalgia rheumatica publication-title: Arthritis Rheum doi: 10.1002/art.24459 – volume: 41 start-page: 1960 year: 1998 ident: 2025080115361602300_keaf164-B22 article-title: Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l’Artérite à Cellules Géantes publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X – volume: 24 start-page: 755 year: 2023 ident: 2025080115361602300_keaf164-B54 article-title: Metformin and Its Immune-Mediated Effects in Various Diseases publication-title: Int J Mol Sci doi: 10.3390/ijms24010755 – volume: 48 start-page: 213 year: 2019 ident: 2025080115361602300_keaf164-B32 article-title: Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study publication-title: Scand J Rheumatol doi: 10.1080/03009742.2018.1506821 – volume: 102 start-page: 383 year: 2016 ident: 2025080115361602300_keaf164-B4 article-title: Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases publication-title: Heart Br Card Soc – volume: 51 start-page: 1193 year: 2021 ident: 2025080115361602300_keaf164-B45 article-title: Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2021.09.006 – volume: 67 start-page: 396 year: 2015 ident: 2025080115361602300_keaf164-B34 article-title: Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study publication-title: Arthritis Care Res doi: 10.1002/acr.22416 – volume: 186 start-page: 108602 year: 2024 ident: 2025080115361602300_keaf164-B14 article-title: A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E) publication-title: Environ Int doi: 10.1016/j.envint.2024.108602 |
SSID | ssj0005138 |
Score | 2.4747677 |
SecondaryResourceType | review_article |
Snippet | Abstract
Objectives
We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis... We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational... Objectives We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of... We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic review and... Abstract Objectives We aimed to analyze the association between cardiovascular risks factors and the onset of giant cell arteritis (GCA) through a systematic... |
SourceID | hal proquest pubmed crossref oup |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 4525 |
SubjectTerms | Arteritis Body weight Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - complications Cardiovascular Diseases - epidemiology Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Dyslipidemia Epidemiology Giant Cell Arteritis - epidemiology Giant Cell Arteritis - etiology Heart Disease Risk Factors Humans Hypertension - epidemiology Life Sciences Meta-analysis Obesity - epidemiology Overweight Risk Factors Smoking - epidemiology Systematic review |
Title | Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40127188 https://www.proquest.com/docview/3235394340 https://www.proquest.com/docview/3180985038 https://hal.science/hal-05039673 |
Volume | 64 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLW6ISFeEN90DGQQD0hTtiR2Upe3gTZVqAxpaqW-RY5jU4Ropi1FaG_8UX4L99pO6mwIDV6i1nWuXd8T58Y595iQ11VSwn1IxRHM_lnEtdKRMFkVyZHI4LrMMXcS2RYn-WTOPyyyxWDwK2AtrZtyX13-Ma_kf7wKZeBXzJL9B892RqEAPoN_4QgehuONfByMbUe4Un2CqaWOt5vqtGzJWikry6TsgsFnQEizhyv4e5bgiSpHLgf6qsyzYw9_042MpBczCYPb06VeQ22n6oQypj9a5rzfKiRYdngH3dRt5Gzf1o_qL118P8Wt2CC6VTWS5tcbgkkpL9u0nE1tmO_cosOpPFtKa0z4gfLrGWnWsemaME8yWITzmV7Y7yu9dVM2z9MoZi4Te1-HZaw3zzu1dI9nEUza-Go3CAB45vRmrt1cnPDWeTCW8PWrlibxpntq3iefiuP5dFrMjhazLXIrBdzbZPRFQEFK7E7r3T9oUzvH7CBs5cC30QudtpZI3O0lZV57NrIx0uweuesfbuihQ-p9MtCrB-T2R0_feEh-BoClHrC0D1iKgKUesBS8QAGwdANYWhtqAUsRsLQD7Fsq6Qau1MHVnt-D6yMyPz6avZ9Efg-QSLE8biKdllrHI8PFmBteyjQ22sRMcG5ErrOyTJRiSVmmVSlRpyqrpDK5hqcwHPBEscdke1Wv9FNCmZQsN7JSmnEu4FwwN8KTKmXGELIMSdQOb3HmpF4KR9FgReiOwrtjSF6BD7qqqNM-OZwWWIYiS-N8xL6D0Tfgohva2239WPhJ5qJgKcsYajjGQ_Ky-xluATjIcqXrNdRBDT6Buk5D8sT5v2uQI7UkEWLn78afkTuba3GXbDfna_0cou2mfGEh-xt_jN8s |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+cardiovascular+risk+factors+and+the+occurrence+of+giant+cell+arteritis%3A+a+systematic+review+and+meta-analysis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Barde%2C+Fran%C3%A7ois&rft.au=Lucas+Pacoureau&rft.au=Elbaz%2C+Alexis&rft.au=Seror%2C+Rapha%C3%A8le&rft.date=2025-08-01&rft.pub=Oxford+Publishing+Limited+%28England%29&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=64&rft.issue=8&rft.spage=4525&rft.epage=4538&rft_id=info:doi/10.1093%2Frheumatology%2Fkeaf164&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon |